|
End-of-day quote
Taipei Exchange
22/10/2026
|
5-day change | 1st Jan Change | ||
| 21.45 TWD | -1.38% |
|
-1.61% | -16.70% |
| 08-13 | GlycoNex Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | GlycoNex Inc Doses First Patient In Phase I Trial Of GNX1021 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.05M | - | - | - | - | - |
| 64.69B | |||||
| 54.78B | |||||
| 53.49B | |||||
| 45.98B | |||||
| 42.94B |
Select your edition
All financial news and data tailored to specific country editions
